As all of the articles published in Antibodies (ISSN: 2073-4468) are in an open access format, you have free and unlimited access to the full texts. We welcome you to read our most highly viewed papers published in 2022 and 2023 listed below.

1. “A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19)”
by Kristin Widyasari and Jinnam Kim
Antibodies 2023, 12(1), 5; https://doi.org/10.3390/antib12010005
Available online: https://www.mdpi.com/2073-4468/12/1/5

2. “Serological Cross-Reactivity in Zoonotic Flaviviral Infections of Medical Importance”
by Priscilla Gomes da Silva, José Augusto Seixas dos Reis, Marcio Nogueira Rodrigues, Quézia da Silva Ardaya and João Rodrigo Mesquita
Antibodies 2023, 12(1), 18; https://doi.org/10.3390/antib12010018
Available online: https://www.mdpi.com/2073-4468/12/1/18

3. “Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster”
by Chin Shern Lau, John Thundyil, May Lin Helen Oh, Soon Kieng Phua, Ya Li Liang, Yanfeng Li, Jianxin Huo, Yuhan Huang, Biyan Zhang, Shengli Xu et al.
Antibodies 2022, 11(4), 70; https://doi.org/10.3390/antib11040070
Available online: https://www.mdpi.com/2073-4468/11/4/70

4. “Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test”
by Tatjana Vilibic-Cavlek, Maja Bogdanic, Ema Borko, Zeljka Hruskar, Denis Zilic, Thomas Ferenc, Irena Tabain, Ljubo Barbic, Mateja Vujica Ferenc, Ivana Ferencak et al.
Antibodies 2023, 12(2), 35; https://doi.org/10.3390/antib12020035
Available online: https://www.mdpi.com/2073-4468/12/2/35

5. “Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis”
by Mepur H. Ravindranath, Fatiha El Hilali, Carly J. Amato-Menker, Hajar El Hilali, Senthamil R. Selvan and Edward J. Filippone
Antibodies 2022, 11(3), 58; https://doi.org/10.3390/antib11030058
Available online: https://www.mdpi.com/2073-4468/11/3/58

6. “Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis”
by Mepur H. Ravindranath, Fatiha El Hilali, Carly J. Amato-Menker, Hajar El Hilali, Senthamil R. Selvan and Edward J. Filippone
Antibodies 2022, 11(3), 58; https://doi.org/10.3390/antib11030058
Available online: https://www.mdpi.com/2073-4468/11/3/58

7. “TLR7 and IgM: Dangerous Partners in Autoimmunity”
by Timm Amendt and Philipp Yu
Antibodies 2023, 12(1), 4; https://doi.org/10.3390/antib12010004
Available online: https://www.mdpi.com/2073-4468/12/1/4

8. “SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform”
by Stefan Hirschberg, Hannes Bauer, Julian Kamhieh-Milz, Frauke Ringel, Christoph Harms, Omar Kamal Eddin, Axel Pruß, Katja Hanack and Kai Schulze-Forster
Antibodies 2022, 11(4), 76; https://doi.org/10.3390/antib11040076
Available online: https://www.mdpi.com/2073-4468/11/4/76

9. “Safety, Tolerability, and Immunogenicity of V160, a Conditionally Replication-Defective Cytomegalovirus Vaccine, in Healthy Japanese Men in a Randomized, Controlled Phase 1 Study”
by Shinya Murata, Nobuyuki Oshima, Takashi Iwasa, Yukako Fukao and Miyuki Sawata
Antibodies 2023, 12(1), 22; https://doi.org/10.3390/antib12010022
Available online: https://www.mdpi.com/2073-4468/12/1/22

10. “Neutralizing Activity of SARS-CoV-2 Antibodies in Patients with COVID-19 and Vaccinated Individuals”
by Tatjana Vilibic-Cavlek, Vladimir Stevanovic, Snjezana Kovac, Ema Borko, Maja Bogdanic, Gorana Miletic, Zeljka Hruskar, Thomas Ferenc, Ivona Coric, Mateja Vujica Ferenc and et al.
Antibodies 2023, 12(4), 61; https://doi.org/10.3390/antib12040061
Available online: https://www.mdpi.com/2073-4468/12/4/61